Provider review
Ro Body tirzepatide review
What Ro Body charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
We re-read Ro Body’s own pages on November 20, 2026. Ro’s pricing pages could not be re-read on November 20, 2026; Ro Body routes members to brand GLP-1s. Ro Body is not scored in our November 20, 2026 computed ranking because it has no compounded tirzepatide price we could read on its own pages that day. Sections below that show July 2026 records are kept as dated history.
What is distinctive about this programme
The annual plan changes the structure, not just the price
Ro's annual prepayment is reported to cut $50 a month from oral medication and $150 a month from injectable medication, and to halve the membership from $149 to $74. That is a larger structural change than most competitors' prepaid discounts, which typically move only the medication line.
On the monthly plan, Zepbound at $399 medication plus $149 membership is $548 all-in — against $449 direct from LillyDirect with no membership. The annual plan closes most of that gap.
Dose escalation applies
Medication prices run $199 to $399 by dose for injectables and $199 to $299 for orals, so the all-in figure moves with titration. The first month is discounted — $299 medication for Zepbound, $149 for oral — and those are introductory rates excluded from our rankings.
What to weigh
Ro is a large, established platform with substantial clinical infrastructure. The pricing question is whether the service layer justifies $1,788 a year on the monthly plan, or $888 on the annual, when both manufacturers sell direct. For patients who want the platform, the annual plan is materially the better structure; for patients who want the medication at the lowest price, LillyDirect and NovoCare are cheaper.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Semaglutide brand injectable, FDA-approved | $348 | Reported |
Where it holds up
- Annual plan reduces both medication cost and membership, halving the latter to $74
- Large established platform with substantial clinical infrastructure
- Wide brand range including both manufacturers' products
Where it does not
- $149 monthly membership on the standard plan, $1,788 a year
- Zepbound at $548 all-in monthly against $449 direct from LillyDirect
- Medication prices escalate by dose
- First-month rates are introductory
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Escalates with dose or not established |
| Lowest captured figure | $348/mo, month-to-month |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
Show this figure as a table
| Category | Points |
|---|---|
| Pricing transparency | 20 pts |
| Total annual cost | 20 pts |
| Clinical oversight | 15 pts |
| Pharmacy transparency | 15 pts |
| Support | 10 pts |
| Regulatory disclosure | 10 pts |
| Accessibility | 10 pts |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| Ro | month_to_month | brand injectable, FDA-approved | — | $348 | — | $348 | Recurring | Reported | 2026-07-06 |
How this sits against the market
Show this figure as a table
| Program | All-in monthly | Read |
|---|---|---|
| Collective | $85.58 | Read 2026-10-15 |
| WellMedr | $89 | Read 2026-10-15 |
| Mondae | $114 | Read 2026-10-15 |
| NexLife | $115 | Read 2026-11-06 |
| Embody | $119 | Read 2026-10-15 |
| NextMeds | $119 | Read 2026-10-15 |
| SnagRx | $119 | Read 2026-10-15 |
| yourEra | $123 | Read 2026-10-15 |
| NewMeMeds | $125 | Older record, 2026-09-20 |
| CoreAge Rx | $129 | Read 2026-10-15 |
| Eden Health | $129 | Read 2026-10-15 |
| SkinnyRx | $129 | Older record, 2026-08-27 |
| GobyMeds | $133 | Read 2026-10-15 |
| Telos RX | $139 | Read 2026-10-15 |
| Sprout Health | $149 | Read 2026-10-15 |
| Strut Health | $149 | Read 2026-10-15 |
| He & She MD | $159 | Read 2026-10-15 |
| Bodybuilding Health+ | $174.67 | Read 2026-10-15 |
| bmiMD | $179 | Older record, 2026-09-17 |
| IVIM Health | $192 | Read 2026-10-15 |
| Alloy | $199 | Read 2026-10-15 |
| TelePep | $214 | Read 2026-10-15 |
| Yucca Health | $225 | Older record, 2026-09-12 |
| Found | $239 | Read 2026-10-15 |
| Pallas Health | $239 | Read 2026-10-15 |
| ShedRx | $239 | Read 2026-10-15 |
| MyDrHank | $240 | Older record, 2026-09-17 |
| Enhance.MD | $280 | Read 2026-10-15 |
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | — |
| Shipping | no | — |
| Higher-dose surcharge | no | — |
| Initial consultation | no | — |
| Required laboratory work | no | — |
| Cancellation or restocking terms | no | — |
A dash means no figure held. How we grade evidence.
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Clinical model
Pharmacy and fulfilment
Billing, cancellation and support
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where Ro Body sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | — | Not answered Pending |
| Clinical oversight and care continuity | 20 pts | — | Not answered Pending |
| State access and operational reliability | 10 pts | — | Not answered Pending |
| Cancellation, billing and support transparency | 10 pts | — | Not answered Pending |
A dash means no figure held. How we grade evidence.
Questions readers actually ask
Is Ro Body the cheapest option?
We will not answer that until the all-in figures are captured for the whole comparison set. A cheapest claim needs a defined comparison group, a stated program type and a capture date, or it is just an adjective.
Is this review sponsored?
No. Reviews here are not sponsored, and no provider can buy a score, a placement or a review. Tirzepatide Ranked is affiliate-supported; the disclosure page explains how.
Is compounded tirzepatide the same as Zepbound?
No. Compounded preparations are not FDA-approved products and there is no generic tirzepatide. Approval of the brand product does not extend to a compounded preparation.
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- Mochi Health Tirzepatide ReviewProviders
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Mounjaro vs ZepboundPillar / Money
- Zepbound vs MounjaroComparisons
- Tirzepatide Cost in 2026Pillar / Money
Related coverage
- PlushCare Tirzepatide Review
- Compounded tirzepatide price index
- What you pay at a maintenance dose
- A 2026 Study Finds Tirzepatide and B12 Can Chemically Bond — Forming a Molecule Not in the Approved Drug
- EVOKE and EVOKE+: Oral Semaglutide Made No Difference to Alzheimer's Progression
- FDA Sends 25 More Warning Letters Over Compounded GLP-1 Marketing Claims
- FDA Proposes Permanent Exclusion of Semaglutide, Tirzepatide and Liraglutide From the 503B Bulks List
- Comment Period on the GLP-1 Bulks Proposal Extended to 30 July
- FDA Signals It Will Restrict GLP-1 Active Ingredients Used in Non-Approved Compounded Products
Tirzepatide Ranked. “Ro Body Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/providers/ro-body/
Quote the capture date beside a figure, not the date you read this page. Why.
How current these prices are: on October 15, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records waiting for a re-read. NexLife’s prices were re-read on November 6, 2026. Any older figure on this page keeps the date it was read.